Published in Biochemistry on November 29, 1994
Hormone-triggered conformational changes within the insulin-receptor ectodomain: requirement for transmembrane anchors. Biochem J (2001) 0.83
Quantitative codon optimisation of DNA libraries encoding sub-random peptides: design and characterisation of a novel library encoding transmembrane domain peptides. Nucleic Acids Res (2002) 0.78
All-Atom Structural Models of the Transmembrane Domains of Insulin and Type 1 Insulin-Like Growth Factor Receptors. Front Endocrinol (Lausanne) (2016) 0.75
SH2 domains recognize specific phosphopeptide sequences. Cell (1993) 17.28
Backbone dynamics of a free and phosphopeptide-complexed Src homology 2 domain studied by 15N NMR relaxation. Biochemistry (1994) 13.94
Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science (2001) 11.56
Phosphatidylinositol 3'-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J (1992) 5.84
Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: crystal structures of the complexed and peptide-free forms. Cell (1993) 5.47
Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol Cell Biol (1994) 5.02
Prevention of fat-induced insulin resistance by salicylate. J Clin Invest (2001) 4.74
Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol Cell (1998) 3.84
Crystal structure of the tyrosine phosphatase SHP-2. Cell (1998) 3.48
Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck. Nature (1993) 3.14
Hypothesis about the function of membrane-buried proline residues in transport proteins. Proc Natl Acad Sci U S A (1986) 2.90
A cascade of tyrosine autophosphorylation in the beta-subunit activates the phosphotransferase of the insulin receptor. J Biol Chem (1988) 2.90
Non-random distribution of amino acids in the transmembrane segments of human type I single span membrane proteins. J Mol Biol (1993) 2.70
Identification and characterization of a high-affinity interaction between v-Crk and tyrosine-phosphorylated paxillin in CT10-transformed fibroblasts. Mol Cell Biol (1993) 2.47
Dileucine-based sorting signals bind to the beta chain of AP-1 at a site distinct and regulated differently from the tyrosine-based motif-binding site. EMBO J (1998) 2.27
Activation of the SH2-containing phosphotyrosine phosphatase SH-PTP2 by its binding site, phosphotyrosine 1009, on the human platelet-derived growth factor receptor. J Biol Chem (1993) 2.13
T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-Xaa-Met motif. Proc Natl Acad Sci U S A (1994) 1.95
Structure of the IRS-1 PTB domain bound to the juxtamembrane region of the insulin receptor. Cell (1996) 1.92
The Cbl phosphotyrosine-binding domain selects a D(N/D)XpY motif and binds to the Tyr292 negative regulatory phosphorylation site of ZAP-70. J Biol Chem (1997) 1.87
SH2 domains exhibit high-affinity binding to tyrosine-phosphorylated peptides yet also exhibit rapid dissociation and exchange. Mol Cell Biol (1993) 1.77
Structure of the regulatory domains of the Src-family tyrosine kinase Lck. Nature (1994) 1.77
Receptor binding redefined by a structural switch in a mutant human insulin. Nature (1991) 1.68
Alpha-helical, but not beta-sheet, propensity of proline is determined by peptide environment. Proc Natl Acad Sci U S A (1996) 1.67
Proline residues in transmembrane helices: structural or dynamic role? Biochemistry (1991) 1.66
Potent stimulation of SH-PTP2 phosphatase activity by simultaneous occupancy of both SH2 domains. J Biol Chem (1995) 1.66
Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2. Nature (1996) 1.65
CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells. J Exp Med (1995) 1.54
Crystal structure of human frataxin. J Biol Chem (2000) 1.54
Polyoma virus middle T antigen-pp60c-src complex associates with purified phosphatidylinositol 3-kinase in vitro. J Biol Chem (1992) 1.52
A measure of helical propensity for amino acids in membrane environments. Nat Struct Biol (1994) 1.52
Nuclear magnetic resonance structure of an SH2 domain of phospholipase C-gamma 1 complexed with a high affinity binding peptide. Cell (1994) 1.48
Activation of the SH2-containing protein tyrosine phosphatase, SH-PTP2, by phosphotyrosine-containing peptides derived from insulin receptor substrate-1. J Biol Chem (1994) 1.46
Crystal structure of the PI 3-kinase p85 amino-terminal SH2 domain and its phosphopeptide complexes. Nat Struct Biol (1996) 1.46
Nuclear magnetic resonance evidence for cis-peptide bonds in proline oligomers. J Am Chem Soc (1970) 1.45
Tandem SH2 domains confer high specificity in tyrosine kinase signaling. J Biol Chem (1998) 1.45
Syp (SH-PTP2) is a positive mediator of growth factor-stimulated mitogenic signal transduction. J Biol Chem (1994) 1.43
Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase. Structure (1994) 1.43
Activated mutants of SHP-2 preferentially induce elongation of Xenopus animal caps. Mol Cell Biol (2000) 1.38
Association of IRS-1 with the insulin receptor and the phosphatidylinositol 3'-kinase. Formation of binary and ternary signaling complexes in intact cells. J Biol Chem (1993) 1.38
Phosphatidylinositol 3-kinase p85 SH2 domain specificity defined by direct phosphopeptide/SH2 domain binding. Biochemistry (1993) 1.38
PTB domains of IRS-1 and Shc have distinct but overlapping binding specificities. J Biol Chem (1995) 1.34
Interaction of Shc with Grb2 regulates association of Grb2 with mSOS. Mol Cell Biol (1995) 1.33
T cell antigen CD28 binds to the GRB-2/SOS complex, regulators of p21ras. Eur J Immunol (1995) 1.30
The SH3 domain-binding T cell tyrosyl phosphoprotein p120. Demonstration of its identity with the c-cbl protooncogene product and in vivo complexes with Fyn, Grb2, and phosphatidylinositol 3-kinase. J Biol Chem (1995) 1.28
Correlation between binding and dynamics at SH2 domain interfaces. Nat Struct Biol (1998) 1.25
Structural basis for IL-4 receptor phosphopeptide recognition by the IRS-1 PTB domain. Nat Struct Biol (1996) 1.25
Uncoupling hydrophobicity and helicity in transmembrane segments. Alpha-helical propensities of the amino acids in non-polar environments. J Biol Chem (1998) 1.24
The phosphotyrosine interaction domain of SHC recognizes tyrosine-phosphorylated NPXY motif. J Biol Chem (1995) 1.23
Nonhydrolyzable phosphotyrosyl mimetics for the preparation of phosphatase-resistant SH2 domain inhibitors. Biochemistry (1994) 1.21
Guidelines for membrane protein engineering derived from de novo designed model peptides. Biopolymers (1998) 1.20
A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance. Diabetologia (2013) 1.19
Inhibition of SH2 domain/phosphoprotein association by a nonhydrolyzable phosphonopeptide. Biochemistry (1992) 1.18
Kinetics of p56lck and p60src Src homology 2 domain binding to tyrosine-phosphorylated peptides determined by a competition assay or surface plasmon resonance. Proc Natl Acad Sci U S A (1993) 1.18
The role of a lymphoid-restricted, Grb2-like SH3-SH2-SH3 protein in T cell receptor signaling. J Biol Chem (1997) 1.18
Stimulation through the T cell receptor induces Cbl association with Crk proteins and the guanine nucleotide exchange protein C3G. J Biol Chem (1996) 1.17
Familial hyperproinsulinemia. Two cohorts secreting indistinguishable type II intermediates of proinsulin conversion. J Clin Invest (1984) 1.15
Evidence for a role for the phosphotyrosine-binding domain of Shc in interleukin 2 signaling. Proc Natl Acad Sci U S A (1996) 1.14
The insulin receptor juxtamembrane region contains two independent tyrosine/beta-turn internalization signals. J Cell Biol (1992) 1.13
Heteronuclear 2D NMR studies of an engineered insulin monomer: assignment and characterization of the receptor-binding surface by selective 2H and 13C labeling with application to protein design. Biochemistry (1991) 1.13
Human GRB-IRbeta/GRB10. Splice variants of an insulin and growth factor receptor-binding protein with PH and SH2 domains. J Biol Chem (1997) 1.13
Glycine and beta-branched residues support and modulate peptide helicity in membrane environments. FEBS Lett (1992) 1.13
Ionophore A23187. Solution conformations of the calcium complex and free acid deduced from proton and carbon-13 nuclear magnetic resonance studies. Biochemistry (1976) 1.12
Interhelical hydrogen bonds in the CFTR membrane domain. Nat Struct Biol (2001) 1.12
Lipocortins 1 and 2 as substrates for the insulin receptor kinase in rat liver. J Biol Chem (1988) 1.11
Anionic phospholipids modulate peptide insertion into membranes. Biochemistry (1997) 1.11
Role of membrane lipids in peptide hormone function: binding of enkephalins to micelles. Proc Natl Acad Sci U S A (1984) 1.11
Rapid T-cell receptor-mediated tyrosine phosphorylation of p120, an Fyn/Lck Src homology 3 domain-binding protein. Proc Natl Acad Sci U S A (1994) 1.11
Specificity of the PTB domain of Shc for beta turn-forming pentapeptide motifs amino-terminal to phosphotyrosine. J Biol Chem (1995) 1.09
The insulin receptor and its substrate: molecular determinants of early events in insulin action. Recent Prog Horm Res (1993) 1.09
Expression, purification, and characterization of SH2-containing protein tyrosine phosphatase, SH-PTP2. J Biol Chem (1993) 1.09
Structure and dynamics of bacteriophage IKe major coat protein in MPG micelles by solution NMR. Biochemistry (1996) 1.08
Retention of native-like oligomerization states in transmembrane segment peptides: application to the Escherichia coli aspartate receptor. Biochemistry (2001) 1.08
Preferential cleavage of des-31,32-proinsulin over intact proinsulin by the insulin secretory granule type II endopeptidase. Implication of a favored route for prohormone processing. J Biol Chem (1992) 1.06
Amino acid composition of the membrane and aqueous domains of integral membrane proteins. Arch Biochem Biophys (1986) 1.06
Folding proteins into membranes. Nat Struct Biol (1996) 1.06
Insulin-stimulated oocyte maturation requires insulin receptor substrate 1 and interaction with the SH2 domains of phosphatidylinositol 3-kinase. Mol Cell Biol (1993) 1.06
T cell activation-dependent association between the p85 subunit of the phosphatidylinositol 3-kinase and Grb2/phospholipase C-gamma 1-binding phosphotyrosyl protein pp36/38. J Biol Chem (1995) 1.05
Bromo-A23187: a nonfluorescent calcium ionophore for use with fluorescent probes. Anal Biochem (1985) 1.05
Phosphorylation of synthetic peptides containing Tyr-Met-X-Met motifs by nonreceptor tyrosine kinases in vitro. J Biol Chem (1993) 1.04
Peptides in membranes: lipid-induced secondary structure of substance P. Biopolymers (1987) 1.03
Antiinsulin receptor antibodies in an insulin-dependent diabetic may arise as autoantiidiotypes. J Clin Endocrinol Metab (1986) 1.03
Packing of coat protein amphipathic and transmembrane helices in filamentous bacteriophage M13: role of small residues in protein oligomerization. J Mol Biol (1995) 1.02
Evidence for a physical association between the Shc-PTB domain and the beta c chain of the granulocyte-macrophage colony-stimulating factor receptor. J Biol Chem (1996) 1.02
Crystal structure of the pleckstrin homology-phosphotyrosine binding (PH-PTB) targeting region of insulin receptor substrate 1. Proc Natl Acad Sci U S A (1999) 1.02
Transmembrane aromatic amino acid distribution in P-glycoprotein. A functional role in broad substrate specificity. J Mol Biol (1994) 1.00
Familial hyperinsulinemia due to a structurally abnormal insulin. Definition of an emerging new clinical syndrome. N Engl J Med (1984) 0.99
Minimum energy conformations of proline-containing helices. Biopolymers (1992) 0.98
Substitution of the insulin receptor transmembrane domain with the c-neu/erbB2 transmembrane domain constitutively activates the insulin receptor kinase in vitro. J Biol Chem (1992) 0.98
Insulin receptors internalize by a rapid, saturable pathway requiring receptor autophosphorylation and an intact juxtamembrane region. J Cell Biol (1991) 0.98
Biochemical and clinical implications of proinsulin conversion intermediates. J Clin Invest (1985) 0.96
Conformations of (X-L-Pro-Y)2 cyclic hexapeptides. Preferred beta-turn conformers and implications for beta turns in proteins. Biochemistry (1981) 0.95
Cyclic peptides. IX. Conformations of a synthetic ion-binding cyclic peptide, cyclo-(pro-gly)3, from circular dichroism and 1H and 13C nuclear magnetic resonance. J Am Chem Soc (1974) 0.95
Substitution of the erbB-2 oncoprotein transmembrane domain activates the insulin receptor and modulates the action of insulin and insulin-receptor substrate 1. Proc Natl Acad Sci U S A (1993) 0.94
Influence of ether linkage on the lamellar to hexagonal phase transition of ethanolamine phospholipids. Biochemistry (1981) 0.94
Identification and functional characterization of a novel mutation of hepatocyte nuclear factor-1alpha gene in a Korean family with MODY3. Diabetologia (2003) 0.93
Cyclic peptides. II. Solution conformations of cyclo(ProlyLserylglycylprolylserylglycyl) from nuclear magnetic resonance. J Am Chem Soc (1972) 0.93
Stimulation through the T cell receptor leads to interactions between SHB and several signaling proteins. Oncogene (1998) 0.92
NMR and photo-CIDNP studies of human proinsulin and prohormone processing intermediates with application to endopeptidase recognition. Biochemistry (1990) 0.92